Angiotensin-Converting Enzyme and Heart Failure
Frontiers in Bioscience-Landmark · 2023
DOI: 10.31083/j.fbl2807150 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Bioscience-Landmark, 2023. Verfasst von Sara Álvarez-Zaballos und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department, Hospital General Universitario Gregorio Marañón, CIBERCV, 28007 Madrid, Spain. Hauptthemen laut MEDLINE: Heart Failure, Angiotensin-Converting Enzyme Inhibitors, Peptidyl-Dipeptidase A. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Pharmacotherapy is the cornerstone treatment for patients with heart failure (HF) that uses drugs targeting the renin-angiotensin-aldosterone system (RAAS), including angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), and the angiotensin receptor-neprilysin inhibitor (ARNI) sacubitril/valsartan. This article reviews the pathophysiology of the RAAS and the neurohormonal changes seen in patients with HF as well as the targets and the mode of action of these drugs. We also assess the role of ACE in ventricular remodeling and summarize the main evidence for the use of ACE-related drugs in HF patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiology Department, Hospital General Universitario Gregorio Marañón, CIBERCV, 28007 Madrid, Spain.
- School of Health and Biomedical Sciences, Universidad Europea, 28670 Madrid, Spain.
- School of Medicine, Universidad Complutense, 28040 Madrid, Spain.
Förderung
- Instituto de Salud Carlos III
Zitieren
APA
Álvarez-Zaballos, S., & Martínez-Sellés, M. (2023). Angiotensin-Converting Enzyme and Heart Failure. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/j.fbl2807150
Vancouver
Álvarez-Zaballos S, Martínez-Sellés M. Angiotensin-Converting Enzyme and Heart Failure. Frontiers in Bioscience-Landmark. 2023. doi:10.31083/j.fbl2807150
BibTeX
@article{lvarezZaballos2023,
author = {Álvarez-Zaballos, Sara and Martínez-Sellés, Manuel},
title = {Angiotensin-Converting Enzyme and Heart Failure},
journal = {Frontiers in Bioscience-Landmark},
year = {2023},
doi = {10.31083/j.fbl2807150}
}
EUVIMED